References
- Anderson, G. W., Goebel, H. H., & Simonati, A. (2013). Human pathology in NCL. Biochim Biophys Acta, 1832 (11), 1807–1826. Epub 2012 Nov 29. PMID: 23200925. https://doi.org/10.1016/j.bbadis.2012.11.014.
- Fukumura, S., Saito, Y., & Saito, T. (2012). Progressive conduction defects and cardiac death in late infantile neuronal ceroid lipofuscinosis. Dev Med Child Neurol, 54 (7), 663–666. Epub 2011 Dec 23. https://doi.org/10.1111/j.1469-8749.2011.04170.x.
- Hofman, I. L., & Taschner, P. E. (1995). Late onset juvenile neuronal ceroid-lipofuscinosis with granular osmiophilic deposits (GROD). Am J Med Genet, 57 (2), 165–167. PMID: 7668323. https://doi.org/10.1002/ajmg.1320570211.
- Hofman, I. L., Van Der Wal, A. C., Dingemans, K. P., & Becker, A. E. (2001). Cardiac pathology in neuronal ceroid lipofuscinoses–a clinicopathologic correlation in three patients. Eur J Paediatr Neurol, 5, A: 213–217. https://doi.org/10.1053/ejpn.2000.0465
- Johannsen, J., Nickel, M., Schulz, A., & Denecke, J. (2016). Considering valproate as a risk factor for rapid exacerbation of complex movement disorder in progressed stages of late-infantile CLN2 disease. Neuropediatrics, 47 (3), 194–196. Epub 2016 Apr 4. PMID: 27043294. https://doi.org/10.1055/s-0036-1579784.
- Johnson, T. B., Cain, J. T., White, K., Ramirez-Montealegre, D., Pearce, D. A., & Weimer, J. M. (2019). Therapeutic landscape for Batten disease: Current treatments and future prospects. Nat Rev Neurol, 15 (3), 161–178. https://doi.org/10.1038/s41582-019-0138-8
- Kousi, M., Lehesjoki, A. E., & Mole, S. E. (2012). Update of the mutations spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Human Mutation, 33 (1), 42–63. Epub 2011 Nov 16. https://doi.org/10.1002/humu.21624.
- Miao, N., Levin, S. W., Baker, E. H., Caruso, R. C., Zhang, Z., Gropman, A., Koziol, D., Wesley, R., Mukherjee, A. B., & Quezado, Z. (2009). Children with infantile neuronal ceroid lipofuscinosis have an increased risk of hypothermia and bradycardia during anesthesia. Anesth Analg, 109 (2), 372–378. https://doi.org/10.1213/ane.0b013e3181aa6e95
- Michielsen, P., Martin, J. J., Vanagt, E., Vrints, C., Gillebert, T., & Snoeck, J. (1984). Cardiac involvement in juvenile ceroid lipofuscinosis of the Spielmeyer-Vogt-Sjögren type: Prospective noninvasive findings in two siblings. Eur Neurol, 23 (3), 166–172. https://doi.org/10.1159/000115699
- Naidu, S., Kaufmann, W. E., Abrams, M. T., Pearlson, G. D., Lanham, D. C., Fredericksen, K. A., Barker, P. B., Horska, A., Golay, X., Mori, S., Wong, D. F., Yablonski, M., Moser, H. W., & Johnston, M. V. (2001). Neuroimaging studies in Rett syndrome. Brain Dev, 23, S62–71. https://doi.org/10.1016/s0387-7604(01)00381-3
- Ostergaard, J. R., Rasmussen, T. B., & Mølgaard, H. (2011). Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease). Neurology, 76 (14), 1245–1251. https://doi.org/10.1212/WNL.0b013e31821435bd
- Pesaola, F., Kohan, R., Cismondi, I. A., Guelbert, N., Pons, P., Oller-Ramirez, A. M., & Noher De Halac, I. (2019). Congenital CLN8 disease of neuronal ceroid lipofuscinosis: A novel phenotype. Rev Neurol, 16;68 (4), 155–159. PMID: 30741402. https://doi.org/10.1016/0006-2952(75)90016-7.
- Simonati, A., Tessa, A., Dalla Bernardina, B., Biancheri, R., Veneselli, E., Tozzi, G., … Santorelli, F. M. (2008). Variant late infantile neuronal ceroid lipofuscinosis because of CLN1 mutations. Pediatr Neurol, 40 (4), 271–276. https://doi.org/10.1016/j.pediatrneurol.2008.10.018
- Yıldırım, M., Köse, E., Keçeli, A. M., Balasar, Ö., & Şimşek, N. (2020). Status dystonicus associated with CLN8 disease. Brain Dev, 24 (4), S0387–7604(20)30329–6. Epub ahead of print. PMID: 33358637. https://doi.org/10.1016/j.braindev.2020.12.005.